Trial intelligence / Profile preview

THN102 in Narcolepsy

NCT02821715Phase 2Completed

Sponsor
Theranexus
Start
Sep 2016
Primary completion
Dec 2018
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of THN102 in narcolepsy, sponsored by Theranexus. Started Sep 2016; status: completed.

02

Drugs

THN102
03

Conditions

narcolepsy

Beyond the preview

Go deeper on NCT02821715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02821715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call